May 2nd - 4th, 2018

Paris, France

#GMTCC

2017 Programme - Amsterdam

Sessions are tentative and subject to change. Last update: 27 April 2017

Download the agenda »

2 May

13.00 - 17.00

MedTech Europe (MEMBERS ONLY)

  • MedTech Europe Compliance & Ethics Committee meeting (CEC) - Part 1 (Ruby Room)
18.00 - 20.00Welcome Reception and Compliance Achievement Award - sponsored by PwC (Winter Garden)

3 May

9.30 - 12.00

MedTech Europe and AdvaMed Meetings (MEMBERS ONLY)

  • MedTech Europe Compliance & Ethics Committee (CEC) - Part 2 (Ruby Room)
  • AdvaMed Device & Diagnostics Compliance Group (DDCG) (Diamond Room)
12.00 - 13.00

GMTCC Registration (Winter Garden)

13.00 - 13.30

Opening Remarks (Grand Ballroom)

Moderator: Ingmar de Gooijer (confirmed)

Speakers:

  • Roeland Van Aelst, VP Healthcare Compliance EMEA & Canada, Johnson & Johnson (confirmed)
  • Bronwen Taylor, VP Compliance & Risk Management, Stryker Corporation (confirmed)

Description: The two associations' Compliance Chairs will discuss the MTE and AdvaMed compliance priorities as well as how the themes addressed in the conference contribute and play into these priorities.

13.30 - 14.00

Keynote Speech (Grand Ballroom)

  • Dutch Ministry of Health, Marcel van Raaij, Director Pharmaceutical Affairs & Medical Technology (confirmed)
14.00 - 15.15

Plenary - Navigating the shift to value: Impact on Compliance (Grand Ballroom)

Speakers:

  • Nacho Abia, President and CEO, Olympus Corporation of America (confirmed)
  • Ted Acosta, Americas Vice Chair Risk Management, EY (confirmed)
  • Ann Bunnenberg, President and COO, EGI Systems (confirmed)
  • Anthony McQuillan, EMEAC Legal & Compliance Vice President, Medtronic (confirmed)
  • Kurt Seiler, Global Head of Compliance, Roche Diabetes Care (confirmed)

Moderator: Ingmar de Gooijer (confirmed)

Description: MedTech companies are navigating a profound transformational shift as the concept of value gains traction in healthcare systems around the world. For companies, the implications are profound, and these new commercial models present opportunities but also significant challenges in the transition from a product-driven industry to one focused on services. What does this change mean for the compliance function?

15.15 - 16.00Networking break (Emerald I, II and III)
16.00 - 17.30

Ask the Experts - (Grand Ballroom)

This session will be set up in roundtable discussions designed for smaller groups of active participants. The time allocated will allow them to get to the heart of key issues. Attendance is limited to 10-12 persons per table. After 40 minutes, the participants are invited to switch tables.

Moderator: Michael Koon, Partner, Norton Rose Fulbright (confirmed)

Tables:

  • CSR and Human Rights - Lead: Milana Chamberlain, Partner, Norton Rose Fulbright (confirmed)
  • MedTech Europe Code / CVS - Lead: Christine Sainvil, Compliance Officer, Ethical MedTech (confirmed) and Pablo Rojas Abad, Legal Officer, MedTech Europe (confirmed)
  • France - Lead: Johanna Benichou, Lawyer, LCH (confirmed) and Olivier Sudre, Compliance & Transparency Officer, Johnson & Johnson Medical Devices France (confirmed)
  • Latin America - Lead: Denis Jacob, Director Global Commercial Compliance, BD (confirmed)
  • China - Lead: Kent D. Kedl, Senior Partner, Control Risks Asia Pacific (confirmed)
  • India - Lead: Dhruv Goyal, Manager Ethics & Compliance Greater India, Edwards Lifesciences (confirmed)
  • Middle East - Lead: Ghadeer Al Yacoub, Regional Compliance & Regulatory Manager, Johnson & Johnson Middle East (confirmed) and Arwa Asiri, Compliance Officer, Ethical MedTech (confirmed)
  • Transparency & Disclosure - Lead: Diva Duong, Vice President Compliance EMEA-APAC, IMS Health (confirmed)
  • Anti-Corruption - Lead: Scott Lane, Founder & CEO, The Red Flag Group (confirmed)
  • Credentialing - Lead: Clive Powell, Senior Manager Compliance and Regulation, ABHI (confirmed) and Brian Lewis, CEO, MEDEC (confirmed)
  • Promotion and Advertising Practices - Lead: Scott Danzis, Partner, Covington & Burling (confirmed)
  • Eastern Europe - Lead: Mariusz Witalis, Partner, EY (confirmed)
  • Managing Risk: ABAC and Third Parties - Lead:Geert van Gansewinkel, Managing Partner Europe & Asia-Pacific, Polaris (confirmed)
18.00 - 19.45

Networking Cocktail - sponsored by The Red Flag Group (Maritime Museum - De Ruyter Chamber and Van Heemskerck Chamber)

Transportation will be provided - Departures at 18:00 and 18:10 from the landing stage at the hotel. No exception.

20.00 - 21.30

GMTCC Networking Dinner - sponsored by EY (Maritime Museum - De Ruyter Chamber and Van Heemskerck Chamber)

Transportation will be provided back to the NH Grand Krasnapolsky Hotel.

4 May

8.00 - 9.00Registration & Welcome Coffee
09.00 - 10.15

Plenary: Less rules, more trust (Grand Ballroom)

Keynote: 

  • Sylvie C. Bleker-van Eyk, Professor, Free University of Amsterdam (confirmed)

Speakers:

  • Elena Bonfiglioli, Senior Director Health Industry EMEA, Microsoft (confirmed)
  • Heidi Jauch, Vice President and Compliance Officer EMEA, Zimmer Biomet (confirmed)
  • Antonio La Regina, President EMEA, Convatec Int. Services GmbH (confirmed)
  • Jean McKiernan, Director, PwC (confirmed)

Moderator: Ingmar de Gooijer (confirmed)

Description: The field of ethics and compliance is highly regulated, both by laws as well as Codes of Ethics, with international, national and local rules which may even contradict each other. This panel will consider the existing research and debate the value of a model where the control is trust-based instead of rules-based.

10.15 - 11.00Networking break (Emerald I, II and III)
11.00 - 12.30

Breakout sessions

Distributors & Evolution of Practices (Ruby Room)

Speakers:
  • Scott Lane, Executive Chairman, The Red Flag Group (confirmed)
  • Rami Rajab, VP Government Affairs, LivaNova & Chair, Mecomed (confirmed)
  • Ilana Shulman, Chief Compliance Officer, Hill-Rom
  • Tamara Tubin, Compliance Director Europe-Canada-Israel, Takeda (confirmed)

Moderator: Wes Porter, Senior VP Chief COmpliance Officer, Wright Medical Group (confirmed)

Description: The MedTech industry is preparing for the 4th industrial revolution and this has also an impact on the Third Party Sales & Marketing Intermediaries. This panel aims at discussing the changes and what this means from distributors and their relationship with MedTech companies, considering the different types of relationships that exist.

Privacy and Big Data: what role for Compliance? (Diamond Room)

Speakers:
  • Peter A. Blenkinsop, International Pharmaceutical Privacy Consortium and Medical Device Privacy Consortium & Partner, Drinker Biddle (confirmed)
  • Carine Cochereau, QRA and Clinical Director EMEA, Cardinal Health (confirmed)
  • Sven Jacobs, Associate, Norton Rose Fulbright LLP (confirmed)
  • Antje Petersen, Group General Counsel, Sonova AG (confirmed)

Moderator: Erik Vollebregt, Partner, Axon Lawyers (confirmed)

Description:Data is key for the MedTech industry, also to drive innovation, but new rules regulating data privacy may need a dierent perspective as to how to deal with Data. The panel will discuss the dierent aspects and approaches important to take into account when considering anything related to data (e.g. cybersecurity; big data; processes).

How to Optimise Educational Grants to Ensure Industry Support to Medical Education? (Amber Room)

Speakers:

  • Simon Dufaur, Head of Strategy, Consulting and Innovation, MCI Benelux (confirmed)
  • Sophia Handtmann, Senior Compliance Professional Corporate Compliance, Fresenius Medical Care AG & Co. KGaA (confirmed)
  • Elke Louwette, EMEA Contract and Grants, WL Gore (confirmed)
  • Richard Peterson, General Counsel, AAOS (confirmed)

Moderator: Hollie Foust, Senior VP Ethics & Compliance, Cardinal Health (confirmed)

Description:With the phase-out of Direct Sponsorship across the globe, Healthcare Organisations and Professional Congress Organisers need to make their educational programs attractive to industry while companies need to define their educational strategies. How to make these two requirements meet to the benefit of the patients and the HCPs?

12.30 - 13.45Networking Lunch (Winter Garden)
13.45 - 15.30

Interactive Sessions on Codes Convergence (Grand Ballroom)

Moderator: Ingmar de Gooijer (confirmed)

The session will be set up to provide a workshop style interaction amongst the participants and the panelists. The panelists will provide an introduction to the three topics, i.e. a common framework among stakeholders, one Code for the healthcare industry and a global MedTech Code, while the participants will be encouraged to give their opinion on the session’s discussion.

Each panel discussion will be followed by a series of live-vote questions to the audience, aiming at uncovering trends and areas of interest.

 

A Global MedTech Code

Speakers:

  • Carlos Gouvêa, President, Brazilian Innovative Health Industry Alliance (ABIIS) (confirmed)
  • Jesus Rueda Rodriguez, Co-Chair, GMTA & International Affairs Director, MedTech Europe (confirmed)
  • Bronwen Taylor, VP Compliance & Risk Management, Stryker Corporation (confirmed)

 A European Lifesciences Industry Code

Speakers:

  • Holger Diener, Managing Director, FSA e.V. & Vice Chair Ethics and Business Integrity Committee, IFPMA (confirmed)
  • Suzanne Durdevic, General Counsel Europe, Boston Scientific & Chair Legal Affairs Committee, MedTech Europe (confirmed)
  • Rita Lenz, Chair, COCIR Code of Conduct Committee & General Counsel, GE (confirmed)
  • Sergio Napolitano, Legal & Trade Director, Medicines for Europe (confirmed)

Stakeholders Code

Speakers:

  • Michel Ballieu, Executive Director, Biomed Alliance (confirmed)
  • Nicola Bedlington, Secretary General, European Patient Forum (confirmed)
  • Andrew Blasi, Associate Director, C&M International (confirmed)
  • Anna Lefevre Skjöldebrand, CEO, Swedish MedTech (confirmed)
15.30 - 15.45

Closing Remarks & Adjournment (Grand Ballroom)

Moderator: Ingmar de Gooijer (confirmed)

Speakers:

  • Aline Lautenberg, Director Legal and Compliance, MedTech Europe (confirmed)
  • Christopher White, Chief Operating Officer and General Counsel, AdvaMed (confirmed)